Osteoporosis and Injection site erythema

Summary:

Injection site erythema is found among people with Osteoporosis, especially for people who are female, 60+ old.

The study analyzes which people have Injection site erythema with Osteoporosis. It is created by eHealthMe based on reports of 4,868 people who have Osteoporosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

4,868 people who have Osteoporosis and Injection Site Erythema are studied.

What is Osteoporosis?

Osteoporosis (bones weak and more likely to break) is found to be associated with 2,570 drugs and 1,861 conditions by eHealthMe.

What is Injection site erythema?

Injection site erythema (redness at injection site) is found to be associated with 2,131 drugs and 1,364 conditions by eHealthMe.

Number of Injection site erythema in Osteoporosis reports submitted per year:

Would you have Injection site erythema when you have Osteoporosis?

Gender of people who have Osteoporosis and experienced Injection site erythema *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Injection site erythema?

Check whether Injection site erythema is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .

Related studies

Treatments, associated drugs and conditions:

Osteoporosis (269,810 reports)
Injection site erythema (105,844 reports)

COVID vaccines that are related to Injection site erythema:

Common drugs associated with Injection site erythema:

All the drugs that are associated with Injection site erythema:

Injection site erythema (2,131 drugs)

Common conditions associated with Injection site erythema:

Rheumatoid arthritis: 31,162 reports
Psoriasis: 9,364 reports
Multiple sclerosis: 7,551 reports
Osteoporosis: 4,868 reports
Crohn's disease: 4,176 reports

All the conditions that are associated with Injection site erythema:

Injection site erythema (1,364 conditions)

How the study uses the data?

The study is based on Injection site erythema and Osteoporosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.